Mary N. Carrington

Mary N. Carrington is a Senior Principal Scientist within the Frederick National Laboratory and head of the HLA Immunogenetics Section in the Laboratory of Integrative Cancer Immunology. Carrington’s group studies the influence of immunogenetic variation on risk of human disease, outcome to therapeutic treatment, and vaccination. These studies include elucidation of the functional basis for the genetic associations identified.

The main goal of the Carrington laboratory is to understand the genetic basis for resistance or susceptibility to human disease conferred by polymorphic immune response loci through direct testing for such effects on specific disease outcomes followed by molecular and cellular biological approaches to determine the biological basis for the genetic association. They study a large variety of disorders including cancer, transplantation outcome, autoimmune and infectious diseases.

Carrington obtained her Ph.D. at Iowa State University in the Immunobiology Department. She did her postdoctoral work in the departments of Immunology and Microbiology at Duke University and the University of North Carolina.